
Tonghua Dongbao Pharmaceutical Co., Ltd.
SSE:600867.SS
Overview | Financials
Company Name | Tonghua Dongbao Pharmaceutical Co., Ltd. |
Symbol | 600867.SS |
Currency | CNY |
Price | 8.08 |
Market Cap | 15,515,789,179 |
Dividend Yield | 2.49% |
52-week-range | 7 - 9.64 |
Industry | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Sheng Leng Chun |
Website | https://www.thdb.com |
An error occurred while fetching data.
About Tonghua Dongbao Pharmaceutical Co., Ltd.
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD